Haleon plc (NYSE:HLN) Receives $10.95 Average Price Target from Brokerages

Shares of Haleon plc (NYSE:HLN - Get Free Report) have been given a consensus rating of "Moderate Buy" by the seven brokerages that are covering the company, Marketbeat.com reports. Three investment analysts have rated the stock with a hold rating, three have assigned a buy rating and one has given a strong buy rating to the company. The average twelve-month price objective among analysts that have updated their coverage on the stock in the last year is $10.95.

A number of brokerages have recently weighed in on HLN. Morgan Stanley lowered Haleon from an "overweight" rating to an "equal weight" rating in a research report on Friday. UBS Group upgraded shares of Haleon to a "strong-buy" rating in a report on Tuesday, October 1st. Finally, Sanford C. Bernstein lowered shares of Haleon from an "outperform" rating to a "market perform" rating in a research note on Wednesday.

Hedge Funds Weigh In On Haleon

Several large investors have recently bought and sold shares of HLN. Fortitude Family Office LLC purchased a new position in shares of Haleon in the 3rd quarter worth approximately $28,000. Versant Capital Management Inc lifted its holdings in Haleon by 2,029.1% during the fourth quarter. Versant Capital Management Inc now owns 3,513 shares of the company's stock worth $34,000 after acquiring an additional 3,348 shares during the period. Toronto Dominion Bank boosted its position in Haleon by 3,470.0% in the third quarter. Toronto Dominion Bank now owns 3,570 shares of the company's stock worth $38,000 after purchasing an additional 3,470 shares during the last quarter. Prospera Private Wealth LLC purchased a new position in Haleon in the third quarter worth $57,000. Finally, BOKF NA grew its stake in Haleon by 68.8% in the 2nd quarter. BOKF NA now owns 6,972 shares of the company's stock valued at $58,000 after purchasing an additional 2,842 shares during the period. 6.67% of the stock is currently owned by institutional investors.

Haleon Stock Down 4.0 %

HLN stock traded down $0.38 during trading on Friday, reaching $9.11. 13,143,704 shares of the stock were exchanged, compared to its average volume of 8,453,087. The firm's 50 day moving average is $9.59 and its 200 day moving average is $9.68. The firm has a market cap of $41.24 billion, a P/E ratio of 26.79, a price-to-earnings-growth ratio of 2.95 and a beta of 0.29. The company has a current ratio of 0.84, a quick ratio of 0.58 and a debt-to-equity ratio of 0.44. Haleon has a twelve month low of $7.89 and a twelve month high of $10.80.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.